Mortality-related risk factors and novel antimicrobial regimens for carbapenem-resistant enterobacteriaceae infections: a systematic review
Q Hu, J Chen, S Sun, S Deng - Infection and Drug Resistance, 2022 - Taylor & Francis
Objective Carbapenem-resistant Enterobacteriaceae (CRE) has become a significant public
health problem in the last decade. We aimed to explore the risk factors of mortality in …
health problem in the last decade. We aimed to explore the risk factors of mortality in …
[HTML][HTML] Risk factors for Klebsiella pneumoniae carbapenemase (KPC) gene acquisition and clinical outcomes across multiple bacterial species
AJ Mathers, K Vegesana, I German-Mesner… - Journal of Hospital …, 2020 - Elsevier
Introduction Risk factors for carbapenemase-producing Enterobacterales (CPE)
acquisition/infection and associated clinical outcomes have been evaluated in the context of …
acquisition/infection and associated clinical outcomes have been evaluated in the context of …
Risk factors of Carbapenem-resistant Enterobacterales intestinal colonization for subsequent infections in hematological patients: a retrospective case-control study
Z Wang, C Shao, J Shao, Y Hao, Y Jin - Frontiers in Microbiology, 2024 - frontiersin.org
Objective Infections caused by Carbapenem-resistant Enterobacterales (CRE) have high
treatment costs, high mortality and few effective therapeutic agents. This study aimed to …
treatment costs, high mortality and few effective therapeutic agents. This study aimed to …
First report of Klebsiella quasipneumoniae harboring blaKPC-2 in Saudi Arabia
Background Nosocomial infections caused by multi-drug resistant Enterobacteriaceae are a
global public health threat that ought to be promptly identified, reported, and addressed …
global public health threat that ought to be promptly identified, reported, and addressed …
[HTML][HTML] Epidemiology of and risk factors for mortality due to carbapenemase-producing organisms (CPO) in healthcare facilities
S Zhao, S Kennedy, MR Perry, J Wilson… - Journal of Hospital …, 2021 - Elsevier
Background Carbapenemase-producing organisms (CPO) have been largely responsible
for the extensive spread of carbapenem resistance, and their prevalence is increasing in …
for the extensive spread of carbapenem resistance, and their prevalence is increasing in …
Colonization resistance against multi-drug-resistant bacteria: a narrative review
R Le Guern, S Stabler, P Gosset, M Pichavant… - Journal of Hospital …, 2021 - Elsevier
Colonization resistance by gut microbiota is a fundamental phenomenon in infection
prevention and control. Hospitalized patients may be exposed to multi-drug-resistant …
prevention and control. Hospitalized patients may be exposed to multi-drug-resistant …
[HTML][HTML] Mortality-related factors in patients with OXA-48 carbapenemase-producing Klebsiella pneumoniae bacteremia
OL Rodríguez, A Sousa, MT Pérez-Rodríguez… - Medicine, 2021 - journals.lww.com
Carbapenemase-producing Enterobacterales constitute a serious public health threat;
however, information on the oxacilinasa (OXA-48)-type is limited. The objective of the study …
however, information on the oxacilinasa (OXA-48)-type is limited. The objective of the study …
Predictors of mortality in patients with infections due to carbapenem-resistant gram-negative bacteria
HO Rivera-Villegas, BA Martinez-Guerra… - Antibiotics, 2023 - mdpi.com
Introduction: Infections caused by carbapenem-resistant Gram-negative bacteria (CR-GNB)
are a significant cause of mortality and represent a serious challenge to health systems. The …
are a significant cause of mortality and represent a serious challenge to health systems. The …
Clinical and economic outcomes attributable to carbapenem-resistant Enterobacterales and delayed appropriate antibiotic therapy in hospitalized patients
K Kengkla, Y Wongsalap, N Chaomuang… - Infection Control & …, 2022 - cambridge.org
Objective: To assess the impact of carbapenem resistance and delayed appropriate
antibiotic therapy (DAAT) on clinical and economic outcomes among patients with …
antibiotic therapy (DAAT) on clinical and economic outcomes among patients with …
Risk Factors for Mortality and Antimicrobial Regimens in Pediatric Intensive Care Unit Patients with Carbapenem-Resistant Enterobacteriaceae Infections: A Six-Year …
P Liu, Y Mai, W Yuan, L Xie, W Ma, J Liu… - Infection and Drug …, 2022 - Taylor & Francis
Purpose Limited data are available on the characteristics, risk factors, and antimicrobial
treatment of critically ill pediatric patients with carbapenem-resistant Enterobacteriaceae …
treatment of critically ill pediatric patients with carbapenem-resistant Enterobacteriaceae …